Drug-specific presentation and outcome of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: a scoping review.
St George-Hyslop F, Cherepacha N, Chugani B, Alabdeen Y, Sanchez-Espino LF, Mahood Q, Sibbald C, Verstegen RHJ.
Clin Exp Dermatol. 2025 Jan 27;50(2):408-411. doi: 10.1093/ced/llae418.
Pharmacology of GABA.
Meldrum B.
Clin Neuropharmacol. 1982;5(3):293-316. doi: 10.1097/00002826-198205030-00004.
Pharmacogenetics.
Dipalma JR.
Am Fam Physician. 1974 Apr;9(4):148-50.
Antiepileptic drug hypersensitivity syndrome.
Schlienger RG, Shear NH.
Epilepsia. 1998;39 Suppl 7:S3-7. doi: 10.1111/j.1528-1157.1998.tb01678.x.
Enzyme induction.
Dollery CT.
Br J Anaesth. 1972 Sep;44(9):961-6. doi: 10.1093/bja/44.9.961.
Drug reactions. XVII. Cutaneous reactions to barbiturates, chloral hydrate and its derivatives.
Almeyda J, Levantine A.
Br J Dermatol. 1972 Mar;86(3):313-6. doi: 10.1111/j.1365-2133.1972.tb02239.x.
Anticonvulsant hypersensitivity syndrome.
Vittorio CC, Muglia JJ.
Arch Intern Med. 1995 Nov 27;155(21):2285-90.
Epilepsy.
Parsonage M.
Practitioner. 1974 Oct;213(1276 SPEC NO):552-9.
Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS): Interest of skin tests in cross-reactivity to phenobarbital.
Rebai J, Romdhane HB, Mansour K, Fadhel NB, Lahouel I, Chadly Z, Chaabane A, Fredj NB, Aouam K.
Therapie. 2024 May-Jun;79(3):398-401. doi: 10.1016/j.therap.2023.06.005. Epub 2023 Jun 16.
[Poisonings].
MYSCHETZKY A.
Nord Med. 1963 Jan 10;69:70-2.
